Interview with Olivier Daubry, General Manager, Celgene France
In only four years Celgene has introduced a number of important products in the French market and is now seen as a preeminent biopharmaceutical company in hematology. As the head…
Address: 3, rue Joseph Monier, Rueil-Malmaison 92500 ,France
Tel: + 33 (0)1 58 83 60 00
With 30 000 employees and 50 subsidiaries, Bristol-Myers Squibb was up to the 11th largest pharmaceutical companies worldwide.
Aware of the expectations from healthcare professionals, patients and governments, BMS is mobilized around a clear strategy: to focus its research on therapeutic priority areas and improve the success rate at each stage of a process development, which spans over ten years.
Internally, an innovative personnel management style contributes to employee development. Externally, Bristol-Myers Squibb undertakes concrete actions to preserve the environment.
BMS FRANCE:
* 3100 employees
* 1st Group subsidiary outside the U.S.
* 7th company of the drug in France
* C.A. 2008: 1 billion €
Cardiovascular
Virology
Oncology
Pain
Neuroscience
Self-medication (OTC)
In only four years Celgene has introduced a number of important products in the French market and is now seen as a preeminent biopharmaceutical company in hematology. As the head…
Octapharma was founded in 1983 and entered decisively in the French market in 1999, when it acquired a plasma facility in Lingolsheim, Alsace. Since then, what have been the main…
As the market leader in the French pre-wholesale market, Depolado had a quite impressive market share growth in the previous 3 years, now being responsible for a quarter of the…
This year Menarini will launch several new products in France to add to its current portfolio. Apart from this, can you tell us about activities and position in France? Our…
The basis of the pharmaceutical business model is changing. Take sales forces for instance, what will be the composition and daily routine? How much mixed media will it require? Currently,…
There is a lot of activity in the pharmaceutical industry and France is no exception especially having passed Germany as the major market of Europe over the past year which…
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
Can you highlight some of the more recent milestones for Stallergenes? Stallergenes has been successful over recent years for several reasons, the first of which is the growth of the…
As Quintiles is present in all major pharmaceutical markets worldwide, what’s the relevance of the French affiliate and what role it plays inside such a globalized organization? France is important…
Biogaran was an initiative from Servier in the mid 1990s before there was even a generic pharmaceutical market in France. Could you speak of your history and of the origins…
Janssen-Cilag is involved in not only selling its products in France but research and production as well. As France is a leading subsidiary, can you speak to the importance of…
See our Cookie Privacy Policy Here
